Patents by Inventor Gary L. Nelsestuen

Gary L. Nelsestuen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Modified vitamin K-dependent polypeptides
    Patent number: 7812132
    Abstract: The invention provides vitamin K-dependent polypeptides with enhanced membrane binding affinity. These polypeptides can be used to modulate clot formation in mammals. Methods of modulating clot formation in mammals are also described.
    Type: Grant
    Filed: March 16, 2006
    Date of Patent: October 12, 2010
    Assignee: Regents of the University of Minnesota
    Inventor: Gary L. Nelsestuen
  • Modified vitamin K-dependent polypeptides
    Patent number: 7750120
    Abstract: The invention provides vitamin K-dependent polypeptides with enhanced membrane binding affinity. These polypeptides can be used to modulate clot formation in mammals. Methods of modulating clot formation in mammals are also described.
    Type: Grant
    Filed: November 2, 2006
    Date of Patent: July 6, 2010
    Assignee: Regents of the University of Minnesota
    Inventor: Gary L Nelsestuen
  • Modified vitamin K-dependent polypeptides
    Patent number: 7662923
    Abstract: The invention provides vitamin K-dependent polypeptides with enhanced membrane binding affinity. These polypeptides can be used to modulate clot formation in mammals. Methods of modulating clot formation in mammals are also described.
    Type: Grant
    Filed: November 2, 2006
    Date of Patent: February 16, 2010
    Assignee: Regents of the University of Minnesota
    Inventor: Gary L Nelsestuen
  • MODIFIED VITAMIN K-DEPENDENT POLYPEPTIDES
    Publication number: 20090280107
    Abstract: The invention provides vitamin K-dependent polypeptides with enhanced membrane binding affinity. These polypeptides can be used to modulate clot formation in mammals. Methods of modulating clot formation in mammals are also described.
    Type: Application
    Filed: October 30, 2007
    Publication date: November 12, 2009
    Inventor: Gary L. Nelsestuen
  • MODIFIED VITAMIN K-DEPENDENT POLYPEPTIDES
    Publication number: 20090281027
    Abstract: The invention provides vitamin K-dependent polypeptides with enhanced membrane binding affinity. These polypeptides can be used to modulate clot formation in mammals. Methods of modulating clot formation in mammals are also described.
    Type: Application
    Filed: October 30, 2007
    Publication date: November 12, 2009
    Inventor: Gary L. Nelsestuen
  • MODIFIED VITAMIN K-DEPENDENT POLYPEPTIDES
    Publication number: 20090280554
    Abstract: The invention provides vitamin K-dependent polypeptides with enhanced membrane binding affinity. These polypeptides can be used to modulate clot formation in mammals. Methods of modulating clot formation in mammals are also described.
    Type: Application
    Filed: October 30, 2007
    Publication date: November 12, 2009
    Inventor: Gary L. Nelsestuen
  • MODIFIED VITAMIN K-DEPENDENT POLYPEPTIDES
    Publication number: 20090275123
    Abstract: The invention provides vitamin K-dependent polypeptides with enhanced membrane binding affinity. These polypeptides can be used to modulate clot formation in mammals. Methods of modulating clot formation in mammals are also described.
    Type: Application
    Filed: October 30, 2007
    Publication date: November 5, 2009
    Inventor: Gary L. Nelsestuen
  • Modified vitamin K. dependent polypeptides
    Patent number: 7612188
    Abstract: The invention provides vitamin K-dependent polypeptides with enhanced membrane binding affinity. These polypeptides can be used to modulate clot formation in mammals. Methods of modulating clot formation in mammals are also described.
    Type: Grant
    Filed: November 2, 2006
    Date of Patent: November 3, 2009
    Assignee: Regents of the University of Minnesota
    Inventor: Gary L Nelsestuen
  • Modified vitamin K-dependent polypeptides
    Patent number: 7553934
    Abstract: The invention provides vitamin K-dependent polypeptides with enhanced membrane binding affinity. These polypeptides can be used to modulate clot formation in mammals. Methods of modulating clot formation in mammals are also described.
    Type: Grant
    Filed: October 6, 2006
    Date of Patent: June 30, 2009
    Assignee: Regents of the University of Minnesota
    Inventor: Gary L Nelsestuen
  • Modified vitamin K-dependent polypeptides
    Patent number: 7553935
    Abstract: The invention provides vitamin K-dependent polypeptides with enhanced membrane binding affinity. These polypeptides can be used to modulate clot formation in mammals. Methods of modulating clot formation in mammals are also described.
    Type: Grant
    Filed: October 6, 2006
    Date of Patent: June 30, 2009
    Assignee: Regents of the University of Minnesota
    Inventor: Gary L Nelsestuen
  • Modified vitamin K-dependent polypeptides
    Patent number: 7479551
    Abstract: The invention provides vitamin K-dependent polypeptides with enhanced membrane binding affinity. These polypeptides can be used to modulate clot formation in mammals. Methods of modulating clot formation in mammals are also described.
    Type: Grant
    Filed: October 6, 2006
    Date of Patent: January 20, 2009
    Assignee: Regents of the University of Minnesota
    Inventor: Gary L Nelsestuen
  • MODIFIED VITAMIN K-DEPENDENT POLYPEPTIDES
    Publication number: 20080207510
    Abstract: The invention provides vitamin K-dependent polypeptides with enhanced membrane binding affinity. These polypeptides can be used to modulate clot formation in mammals. Methods of modulating clot formation in mammals are also described.
    Type: Application
    Filed: October 29, 2007
    Publication date: August 28, 2008
    Inventor: Gary L. Nelsestuen
  • Modified vitamin K-dependent polypeptides
    Patent number: 7314917
    Abstract: The invention provides vitamin K-dependent polypeptides with enhanced membrane binding affinity. These polypeptides can be used to modulate clot formation in mammals. Methods of modulating clot formation in mammals are also described.
    Type: Grant
    Filed: April 21, 2004
    Date of Patent: January 1, 2008
    Assignee: Regents of the University of Minnesota
    Inventor: Gary L. Nelsestuen
  • Modified vitamin K-dependent polypeptides
    Patent number: 7294699
    Abstract: The invention provides vitamin k-dependent polypeptides with enhanced membrane binding affinity. These polypeptides can be used to modulate clot formation in mammals. Methods of modulating clot formation in mammals are also described.
    Type: Grant
    Filed: May 27, 2004
    Date of Patent: November 13, 2007
    Assignee: Regents of the University of Minnesota
    Inventor: Gary L. Nelsestuen
  • Modified vitamin K-dependent polypeptides
    Patent number: 7247708
    Abstract: The invention provides vitamin K-dependent polypeptides with enhanced membrane binding affinity. These polypeptides can be used to modulate clot formation in mammals. Methods of modulating clot formation in mammals are also described.
    Type: Grant
    Filed: November 18, 2002
    Date of Patent: July 24, 2007
    Assignee: Regents of the University of Minnesota
    Inventor: Gary L. Nelsestuen
  • Modified vitamin K-dependent polypeptides
    Patent number: 7220837
    Abstract: The invention provides vitamin K-dependent polypeptides with enhanced membrane binding affinity. These polypeptides can be used to modulate clot formation in mammals. Methods of modulating clot formation in mammals are also described.
    Type: Grant
    Filed: April 28, 2000
    Date of Patent: May 22, 2007
    Assignee: Regents of the University of Minnesota
    Inventor: Gary L. Nelsestuen
  • Methods for detecting activity of clottings factors
    Patent number: 7160540
    Abstract: Whole blood assays and kits are described for evaluating dosage of factor VIIa or activated protein C, as well as for monitoring responsiveness to factor VIIa or activated protein C.
    Type: Grant
    Filed: June 26, 2001
    Date of Patent: January 9, 2007
    Assignee: Regents of the University of Minnesota
    Inventor: Gary L. Nelsestuen
  • Modified vitamin K-dependent polypeptides
    Publication number: 20040220106
    Abstract: The invention provides vitamin k-dependent polypeptides with enhanced membrane binding affinity. These polypeptides can be used to modulate clot formation in mammals. Methods of modulating clot formation in mammals are also described.
    Type: Application
    Filed: May 27, 2004
    Publication date: November 4, 2004
    Applicant: Regents of the University of Minnesota, a MN corporation
    Inventor: Gary L. Nelsestuen
  • Modified vitamin K-dependent polypeptides
    Patent number: 6762286
    Abstract: The invention provides vitamin k-dependent polypeptides with enhanced membrane binding affinity. These polypeptides can be used to modulate clot formation in mammals. Methods of modulating clot formation in mammals are also described.
    Type: Grant
    Filed: March 12, 2001
    Date of Patent: July 13, 2004
    Assignee: Regents of the University of Minnesota
    Inventor: Gary L. Nelsestuen
  • Modified vitamin K-dependent polypeptides
    Patent number: 6747003
    Abstract: The invention provides vitamin K-dependent polypeptides with enhanced membrane binding affinity. These polypeptides can be used to modulate clot formation in mammals. Methods of modulating clot formation in mammals are also described.
    Type: Grant
    Filed: February 3, 2000
    Date of Patent: June 8, 2004
    Assignee: Regents of the University of Minnesota
    Inventor: Gary L. Nelsestuen